Analysts Conflicted on These Healthcare Names: Acrivon Therapeutics, Inc. (ACRV), Align Tech (ALGN) and Perrigo Company (PRGO)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Acrivon Therapeutics, Inc. (ACRV – Research Report), Align Tech (ALGN – Research Report) and Perrigo Company (PRGO – Research Report).

Acrivon Therapeutics, Inc. (ACRV)

In a report released today, Edward Tenthoff from Piper Sandler initiated coverage with a Buy rating on Acrivon Therapeutics, Inc. and a price target of $6.00. The company’s shares closed last Friday at $1.41.

According to TipRanks.com, Tenthoff ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -21.6% and a 26.0% success rate. Tenthoff covers the Healthcare sector, focusing on stocks such as CAMP4 Therapeutics Corporation, Arrowhead Pharmaceuticals, and Milestone Pharmaceuticals.

Currently, the analyst consensus on Acrivon Therapeutics, Inc. is a Strong Buy with an average price target of $12.33.

See today’s best-performing stocks on TipRanks >>

Align Tech (ALGN)

Piper Sandler analyst Jason Bednar maintained a Buy rating on Align Tech today and set a price target of $250.00. The company’s shares closed last Friday at $179.82, close to its 52-week low of $157.57.

According to TipRanks.com, Bednar has 0 stars on 0-5 stars ranking scale with an average return of -7.0% and a 36.0% success rate. Bednar covers the Healthcare sector, focusing on stocks such as GE Healthcare Technologies Inc, Merit Medical Systems, and Alpha Tau Medical Ltd.

Currently, the analyst consensus on Align Tech is a Moderate Buy with an average price target of $231.00, representing a 28.2% upside. In a report issued on April 28, Stifel Nicolaus also maintained a Buy rating on the stock with a $275.00 price target.

Perrigo Company (PRGO)

In a report released today, Korinne Wolfmeyer from Piper Sandler maintained a Hold rating on Perrigo Company, with a price target of $27.00. The company’s shares closed last Friday at $25.63.

According to TipRanks.com, Wolfmeyer ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -5.4% and a 31.4% success rate. Wolfmeyer covers the NA sector, focusing on stocks such as The Estée Lauder Companies, Xponential Fitness, and Bath & Body Works.

Currently, the analyst consensus on Perrigo Company is a Moderate Buy with an average price target of $34.50.

Read More on ACRV:

• Biotech Alert: Searches spiking for these stocks today
• Acrivon Therapeutics to present data from analyses of ACR-2316 at AACR
• Acrivon Therapeutics Reports Progress in Cancer Drug Development
• Acrivon Therapeutics Appoints New Chief Medical Officer
• Acrivon appoints Mansoor Raza Mirza as Chief Medical Officer